Pelvic fixation in short construct lumbo-sacral fusions with a novel porous ingrowth implant: results from a prospective, multicenter, observational study.
6 affiliations
- 1Department of Orthopedic Surgery and Neurosurgery, University of Minnesota, Minneapolis, MN, USA.
- 2Pinehurst Surgical Center, Pinehurst, NC, USA.
- 3Department of Neurosurgery, University of South Alabama, Mobile, AL, USA.
- 4Department of Orthopedic Surgery, Corewell Health, Southfield, MI, USA.
- 5Northwell Health, New York, NY, USA.
- 6Department of Orthopedic Surgery, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Abstract
The indications for pelvic fixation (PF) in short constructs are unclear. This subgroup analysis of the prospective, multicenter, observational Pelvic Fixation and Fusion During Multilevel Spine Surgery (PAULA) clinical study aimed to better define common indications and early outcomes of PF in short-segment lumbar fusions (two to three treated levels) using a novel porous-ingrowth implant. This was a prospective, multicenter, pragmatic observational study with minimal eligibility criteria to ensure generalizability in the real-world setting. Patients who underwent short-segment lumbar fusion of three or fewer levels to the pelvis with at least 6 months of follow-up were included in this analysis. Indications and outcomes of PF were recorded. A total of 32 subjects underwent short-segment lumbar spinal fusions with extension to the pelvis. Of these, 43.8% were revision surgeries. Mean [standard deviation (SD)] age and body mass index (BMI) were 63.1 (14.6) years and 33.2 (6.7) kg/m2, respectively. The upper instrumented vertebra (UIV) was L3 in 65.6% of cases and L4 in 34.4%. Surgeons listed multiple indications for PF in each case. Osteoporosis was the most frequently selected indication for PF, accounting for 20.5% of the total 83 indications recorded across the 32 patients (n=17), followed by pseudarthrosis (16.9%, n=14) and spondylolisthesis (15.7%, n=13). The mean (SD) Oswestry Disability Index (ODI) improved from 49.6 (18.2) at baseline to 35.6 (20.9) at 12 months. Mean numerical rating scale (NRS) back pain improved from 7.2 (2.8) at baseline to 3.6 (3.2) at 12 months. There were no instances of S1 or pelvic implant failure and no complications attributable to PF at 6- or 12-month follow-up. PF using a porous-ingrowth implant was feasible as an adjunct in short-segment constructs in this small, single-arm study, and may be particularly applicable in patients with osteoporosis or in revision cases indicated for pseudarthrosis. Further studies are needed to establish appropriate clinical indications and comparative safety.
Related
- Twelve-month outcomes after fixation-free, 3-dimensional, lightweight SWING-Mesh implantation for minimally-invasive inguinal hernia repair: a multicenter prospective observational study
- Incisional hernia prevention in high-risk midline laparotomy using onlay PVDF mesh: multicenter prospective observational study
- A Prospective, Observational, Open-Label, Nonrandomized, Multicenter Study Measuring Functional Outcomes in a Novel Interspinous Stabilization Device in Patients With Low Back Pain: 12-Month Results for the REFINE Study
- Surgical Impact on Postoperative Morbidity in Colorectal Cancer with Peritoneal Metastasis: A Multicenter Prospective Observational Study.
- Real-world effectiveness and safety of enavogliflozin in patients with type 2 diabetes: A 24-week prospective multicenter observational study in Korea.
BibTeX
@article{martin2026pelvic,
title = {{Pelvic fixation in short construct lumbo-sacral fusions with a novel porous ingrowth implant: results from a prospective, multicenter, observational study.}},
author = {Christopher T Martin and Dan Williams and Alexander Lemons and Richard Menger and Jad Khalil and John Caridi and Christopher J Kleck},
journal = {Journal of spine surgery (Hong Kong)},
year = {2026},
month = sep,
doi = {10.21037/jss-2026-0211},
url = {https://europepmc.org/article/MED/42996600},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Pelvic fixation in short construct lumbo-sacral fusions with a novel porous ingrowth implant: results from a prospective, multicenter, observational study.
AU - Christopher T Martin
AU - Dan Williams
AU - Alexander Lemons
AU - Richard Menger
AU - Jad Khalil
AU - John Caridi
AU - Christopher J Kleck
PY - 2026
DA - 2026/09/29
JO - Journal of spine surgery (Hong Kong)
DO - 10.21037/jss-2026-0211
UR - https://europepmc.org/article/MED/42996600
AB - The indications for pelvic fixation (PF) in short constructs are unclear. This subgroup analysis of the prospective, multicenter, observational Pelvic Fixation and Fusion During Multilevel Spine Surgery (PAULA) clinical study aimed to better define common indications and early outcomes of PF in short-segment lumbar fusions (two to three treated levels) using a novel porous-ingrowth implant. This was a prospective, multicenter, pragmatic observational study with minimal eligibility criteria to ensure generalizability in the real-world setting. Patients who underwent short-segment lumbar fusion of three or fewer levels to the pelvis with at least 6 months of follow-up were included in this analysis. Indications and outcomes of PF were recorded. A total of 32 subjects underwent short-segment lumbar spinal fusions with extension to the pelvis. Of these, 43.8% were revision surgeries. Mean [standard deviation (SD)] age and body mass index (BMI) were 63.1 (14.6) years and 33.2 (6.7) kg/m2, respectively. The upper instrumented vertebra (UIV) was L3 in 65.6% of cases and L4 in 34.4%. Surgeons listed multiple indications for PF in each case. Osteoporosis was the most frequently selected indication for PF, accounting for 20.5% of the total 83 indications recorded across the 32 patients (n=17), followed by pseudarthrosis (16.9%, n=14) and spondylolisthesis (15.7%, n=13). The mean (SD) Oswestry Disability Index (ODI) improved from 49.6 (18.2) at baseline to 35.6 (20.9) at 12 months. Mean numerical rating scale (NRS) back pain improved from 7.2 (2.8) at baseline to 3.6 (3.2) at 12 months. There were no instances of S1 or pelvic implant failure and no complications attributable to PF at 6- or 12-month follow-up. PF using a porous-ingrowth implant was feasible as an adjunct in short-segment constructs in this small, single-arm study, and may be particularly applicable in patients with osteoporosis or in revision cases indicated for pseudarthrosis. Further studies are needed to establish appropriate clinical indications and comparative safety.
SN - 2414-469X
SN - 2414-4630
ER -